Tags

Type your tag names separated by a space and hit enter

Hypertensive Conditions: Hypertensive Disorders in Pregnancy.
FP Essent. 2022 Nov; 522:25-33.FE

Abstract

Hypertensive disorders in pregnancy (HDP) represent a spectrum of disease that affect women through pregnancy and the immediate postpartum period. These conditions are associated with significant morbidity and mortality during and after pregnancy and have been linked to cardiovascular disease later in life. The HDP spectrum includes gestational hypertension (HTN), preeclampsia, eclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, chronic HTN, and chronic HTN with superimposed preeclampsia. Low-dose aspirin is recommended as a preventive drug after 12 weeks' gestation in women who are at high risk of preeclampsia. In HDP, close blood pressure (BP) monitoring, laboratory evaluation, and fetal assessment are warranted. Labetalol and nifedipine extended release are first-line oral antihypertensives for outpatient BP management of chronic HTN; labetalol, hydralazine, and nifedipine immediate release are used for hospitalized patients. HDP may develop or progress in the postpartum period; continued vigilance is important in the puerperium.

Authors+Show Affiliations

Naval Hospital Jacksonville Family Medicine Residency, 2080 Child St, Jacksonville, FL 32214.Naval Hospital Jacksonville, 2080 Child St, Jacksonville, FL 32214.Naval Hospital Jacksonville Family Medicine Residency, 2080 Child St, Jacksonville, FL 32214.Naval Hospital Jacksonville Family Medicine Residency, 2080 Child St, Jacksonville, FL 32214.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

36374636

Citation

Kipnis, Cecilia M., et al. "Hypertensive Conditions: Hypertensive Disorders in Pregnancy." FP Essentials, vol. 522, 2022, pp. 25-33.
Kipnis CM, Daly PL, Goodwin ET, et al. Hypertensive Conditions: Hypertensive Disorders in Pregnancy. FP Essent. 2022;522:25-33.
Kipnis, C. M., Daly, P. L., Goodwin, E. T., & Smith, D. K. (2022). Hypertensive Conditions: Hypertensive Disorders in Pregnancy. FP Essentials, 522, 25-33.
Kipnis CM, et al. Hypertensive Conditions: Hypertensive Disorders in Pregnancy. FP Essent. 2022;522:25-33. PubMed PMID: 36374636.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hypertensive Conditions: Hypertensive Disorders in Pregnancy. AU - Kipnis,Cecilia M, AU - Daly,Patrick L, AU - Goodwin,Emily T, AU - Smith,Dustin K, PY - 2022/11/14/entrez PY - 2022/11/15/pubmed PY - 2022/11/18/medline SP - 25 EP - 33 JF - FP essentials JO - FP Essent VL - 522 N2 - Hypertensive disorders in pregnancy (HDP) represent a spectrum of disease that affect women through pregnancy and the immediate postpartum period. These conditions are associated with significant morbidity and mortality during and after pregnancy and have been linked to cardiovascular disease later in life. The HDP spectrum includes gestational hypertension (HTN), preeclampsia, eclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, chronic HTN, and chronic HTN with superimposed preeclampsia. Low-dose aspirin is recommended as a preventive drug after 12 weeks' gestation in women who are at high risk of preeclampsia. In HDP, close blood pressure (BP) monitoring, laboratory evaluation, and fetal assessment are warranted. Labetalol and nifedipine extended release are first-line oral antihypertensives for outpatient BP management of chronic HTN; labetalol, hydralazine, and nifedipine immediate release are used for hospitalized patients. HDP may develop or progress in the postpartum period; continued vigilance is important in the puerperium. SN - 2159-3000 UR - https://www.unboundmedicine.com/medline/citation/36374636/Hypertensive_Conditions:_Hypertensive_Disorders_in_Pregnancy. DB - PRIME DP - Unbound Medicine ER -